Market Forecast By Application (Skin Allergies, Rhuematology Indications, Endocrinology, Acute Respiratory Diseases, Others), By End User (Hospitals, Clinics, Research Institutes, Others) And Competitive Landscape
Product Code: ETC417500 | Publication Date: Oct 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India corticosteroids market import shipment exhibited a moderate growth trend with a CAGR of 4.7% from 2020 to 2024. However, the growth rate slightly decreased between 2023 and 2024, indicating a potential stabilization in market expansion.
The India Corticosteroids Market Report thoroughly covers the market by application and end user. The India Corticosteroids Market Outlook report provides an unbiased and detailed analysis of the ongoing India Corticosteroids Market trends, opportunities/high growth areas, and market drivers. This would help the stakeholders devise and align their market strategies according to the current and future market dynamics.
The India corticosteroids market has attained prominent growth and is anticipated to grow at a higher growth rate during the forecast period. This growth can be attributed to various factors such as the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for topical corticosteroids in dermatology.
According to 6Wresearch, India Corticosteroids Market size is projected to rise at a CAGR of 5.7% during 2025-2031. One of the major drivers for the market growth in India is the high prevalence of chronic diseases such as asthma, arthritis, and inflammatory bowel disease. According to a report by the World Health Organization (WHO), around 5% of India's population suffers from asthma and this number is expected to increase in the coming years. Moreover, the ageing population in India is also a major factor contributing to the growth of the corticosteroid market. With an estimated 104 million people aged 60 years and above in 2021, this number is expected to reach 340 million by 2050.
However, there are also certain challenges that may hinder the growth of the Indian corticosteroids market. One of them is the high cost associated with these medications. Many patients in India cannot afford expensive treatments, resulting in lower adoption rates and hindering market growth.
The India corticosteroids market is highly competitive, with several key players operating in the market. Some of the leading pharmaceutical companies in this market include Pfizer Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, and Merck & Co. Inc. These players are constantly striving to innovate and introduce new products to cater to the increasing demand for corticosteroids in India. These key players are contributing to the India Corticosteroids Market growth.
The Government of India has taken several initiatives to promote the use of corticosteroids in the country. The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of pharmaceutical drugs in India, including corticosteroids. Furthermore, the government has implemented various policies and schemes to improve healthcare infrastructure and make quality medicines accessible and affordable for all.
The future of the India corticosteroids market looks promising, with increasing investments in research and development activities by key players and advancements in technology. The use of biodegradable corticosteroids is gaining traction as these are considered safer and more effective. Moreover, the growing incidences of chronic diseases and increasing healthcare expenditure in the country are expected to drive market growth.
According to Sachin, Senior Research Analyst, 6Wresearch, the skin allergies segment is currently the largest application segment for corticosteroids in India, accounting for a significant portion of the overall market share. This can be attributed to the high prevalence of skin allergies in the country, as well as the effectiveness of corticosteroids in treating these conditions.
The hospitals segment holds the largest share and is expected to continue its dominance in the coming years. Hospitals are majorly responsible for catering to a large number of patients with various inflammatory and autoimmune diseases that require treatment with corticosteroids.
The report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Corticosteroids Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 India Corticosteroids Market - Industry Life Cycle |
3.4 India Corticosteroids Market - Porter's Five Forces |
3.5 India Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring corticosteroid treatment |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various medical conditions |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of corticosteroid drugs |
4.3.2 Potential side effects associated with long-term corticosteroid use |
4.3.3 Increasing competition from alternative treatment options such as biologics and non-steroidal anti-inflammatory drugs (NSAIDs) |
5 India Corticosteroids Market Trends |
6 India Corticosteroids Market, By Types |
6.1 India Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Corticosteroids Market Revenues & Volume, By Application, 2020 - 2030F |
6.1.3 India Corticosteroids Market Revenues & Volume, By Skin Allergies, 2020 - 2030F |
6.1.4 India Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2020 - 2030F |
6.1.5 India Corticosteroids Market Revenues & Volume, By Endocrinology, 2020 - 2030F |
6.1.6 India Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2020 - 2030F |
6.1.7 India Corticosteroids Market Revenues & Volume, By Others, 2020 - 2030F |
6.2 India Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 India Corticosteroids Market Revenues & Volume, By Hospitals, 2020 - 2030F |
6.2.3 India Corticosteroids Market Revenues & Volume, By Clinics, 2020 - 2030F |
6.2.4 India Corticosteroids Market Revenues & Volume, By Research Institutes, 2020 - 2030F |
6.2.5 India Corticosteroids Market Revenues & Volume, By Others, 2020 - 2030F |
7 India Corticosteroids Market Import-Export Trade Statistics |
7.1 India Corticosteroids Market Export to Major Countries |
7.2 India Corticosteroids Market Imports from Major Countries |
8 India Corticosteroids Market Key Performance Indicators |
8.1 Prescription rates of corticosteroids by healthcare providers |
8.2 Patient adherence to corticosteroid treatment regimens |
8.3 Number of new corticosteroid drug formulations or delivery methods introduced to the market |
9 India Corticosteroids Market - Opportunity Assessment |
9.1 India Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Corticosteroids Market - Competitive Landscape |
10.1 India Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 India Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |